The purpose of this cooperative agreement is to advance strategic and applied research in support of malaria and neglected tropical disease (NTD) control and elimination, particularly in sub-Saharan Africa, Asia, and Hispaniola.
Through this funding announcement, the Division of Parasitic Diseases
and Malaria (DPDM) seeks to fund critical implementation research projects and evaluation activities in two critical areas:
Malaria and Component B:
The Centers for Disease Control and Prevention (CDC) is a partner of the Roll Back Malaria (RBM) initiative and a World Health Organization (WHO) Collaborating Center, and seeks to support and coordinate global malaria program scale-up, surveillance, and evaluation efforts in malaria endemic countries.
In addition, along with the US Agency for International Development (USAID), CDC’s Malaria Branch co-implements the US President’s Malaria Initiative.
While there has been tremendous recent progress toward malaria elimination, there is a critical need for ongoing research to improve malaria control interventions.
Supported malaria research activities will be based on the WHO Global Technical Strategy for Malaria 2016—2030, will be designed to yield high impact public health findings, and to improve strategies aimed at controlling and ultimately eliminating malaria.
CDC also provides technical assistance in support of, and conducts operational research related to, efforts to eliminate onchocerciasis where possible, eliminate blinding trachoma and lymphatic filariasis as public health problems, and control schistosomiasis and soil-transmitted helminths.
CDC supports global NTD control and elimination efforts in collaboration with USAID and WHO.
Supported NTD research strategies will be focused on identifying strategies to strengthen NTD program scale up, and surveillance and evaluation efforts in NTD endemic countries in order to meet elimination and control goals